E I Walter

1.3k total citations
12 papers, 1.1k citations indexed

About

E I Walter is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, E I Walter has authored 12 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in E I Walter's work include Complement system in diseases (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Toxin Mechanisms and Immunotoxins (2 papers). E I Walter is often cited by papers focused on Complement system in diseases (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Toxin Mechanisms and Immunotoxins (2 papers). E I Walter collaborates with scholars based in United States, Switzerland and Japan. E I Walter's co-authors include M. Edward Medof, William L. Roberts, Terrone L. Rosenberry, Victor Nussenzweig, Dan Knowles, Joanne L. Rutgers, William D. Ratnoff, Robert Haas, Mark L. Tykocinski and Nai‐Kong V. Cheung and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

E I Walter

12 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E I Walter United States 11 536 387 208 170 158 12 1.1k
Gerald L. Waneck United States 23 781 1.5× 736 1.9× 200 1.0× 183 1.1× 117 0.7× 36 1.7k
Nancy A. Cochran United States 10 543 1.0× 852 2.2× 265 1.3× 111 0.7× 105 0.7× 11 1.5k
Toshihiko Kobayashi Japan 14 871 1.6× 436 1.1× 256 1.2× 144 0.8× 63 0.4× 38 1.3k
Karel Odink Switzerland 13 523 1.0× 823 2.1× 58 0.3× 107 0.6× 79 0.5× 14 1.4k
D T Fearon United States 16 1.3k 2.5× 359 0.9× 315 1.5× 100 0.6× 139 0.9× 17 1.7k
William D. Linscott United States 15 608 1.1× 251 0.6× 222 1.1× 115 0.7× 173 1.1× 46 1.1k
H Mostowski United States 16 1.2k 2.2× 443 1.1× 337 1.6× 187 1.1× 79 0.5× 22 1.9k
Dale R. Taylor United Kingdom 9 892 1.7× 522 1.3× 102 0.5× 144 0.8× 78 0.5× 12 1.6k
R H Carter United States 8 1.1k 2.1× 278 0.7× 309 1.5× 110 0.6× 47 0.3× 8 1.4k
Ji Zhao United States 15 591 1.1× 926 2.4× 70 0.3× 91 0.5× 299 1.9× 21 1.6k

Countries citing papers authored by E I Walter

Since Specialization
Citations

This map shows the geographic impact of E I Walter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E I Walter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E I Walter more than expected).

Fields of papers citing papers by E I Walter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E I Walter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E I Walter. The network helps show where E I Walter may publish in the future.

Co-authorship network of co-authors of E I Walter

This figure shows the co-authorship network connecting the top 25 collaborators of E I Walter. A scholar is included among the top collaborators of E I Walter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E I Walter. E I Walter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Chen, Rui, E I Walter, G.J. Parker, et al.. (1998). Mammalian glycophosphatidylinositol anchor transfer to proteins and posttransfer deacylation. Proceedings of the National Academy of Sciences. 95(16). 9512–9517. 60 indexed citations
2.
Frisa, Phyllis S., E I Walter, Lei Ling, Hsing‐Jien Kung, & James W. Jacobberger. (1996). Stepwise transformation of astrocytes by simian virus 40 large T antigen and epidermal growth factor receptor overexpression.. PubMed. 7(2). 223–33. 10 indexed citations
3.
Walter, E I, William D. Ratnoff, Kristin E. Long, J W Kazura, & M. Edward Medof. (1992). Effect of glycoinositolphospholipid anchor lipid groups on functional properties of decay-accelerating factor protein in cells.. Journal of Biological Chemistry. 267(2). 1245–1252. 42 indexed citations
4.
Mold, Carolyn, E I Walter, & M. Edward Medof. (1990). The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factor.. The Journal of Immunology. 145(11). 3836–3841. 15 indexed citations
5.
Walter, E I, William L. Roberts, Terrone L. Rosenberry, William D. Ratnoff, & M. Edward Medof. (1990). Structural basis for variations in the sensitivity of human decay accelerating factor to phosphatidylinositol-specific phospholipase C cleavage.. The Journal of Immunology. 144(3). 1030–1036. 119 indexed citations
6.
Lass, Jonathan H., E I Walter, Terry E. Burris, et al.. (1990). Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland.. PubMed. 31(6). 1136–48. 72 indexed citations
7.
Lederman, Michael M., Scott F. Purvis, E I Walter, John T. Carey, & M. Edward Medof. (1989). Heightened complement sensitivity of acquired immunodeficiency syndrome lymphocytes related to diminished expression of decay-accelerating factor.. Proceedings of the National Academy of Sciences. 86(11). 4205–4209. 29 indexed citations
8.
Cheung, Nai‐Kong V., et al.. (1988). Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro.. Journal of Clinical Investigation. 81(4). 1122–1128. 118 indexed citations
9.
Tykocinski, Mark L., Hui‐Kuo G. Shu, E I Walter, et al.. (1988). Glycolipid reanchoring of T-lymphocyte surface antigen CD8 using the 3' end sequence of decay-accelerating factor's mRNA.. Proceedings of the National Academy of Sciences. 85(10). 3555–3559. 47 indexed citations
10.
Kammer, Gary M., E I Walter, & M. Edward Medof. (1988). Association of cytoskeletal re-organization with capping of the complement decay-accelerating factor on T lymphocytes.. The Journal of Immunology. 141(9). 2924–2928. 22 indexed citations
11.
Medof, M. Edward, E I Walter, Joanne L. Rutgers, Dan Knowles, & Victor Nussenzweig. (1987). Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids.. The Journal of Experimental Medicine. 165(3). 848–864. 281 indexed citations
12.
Medof, M. Edward, E I Walter, William L. Roberts, Robert Haas, & Terrone L. Rosenberry. (1986). Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid. Biochemistry. 25(22). 6740–6747. 247 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026